Aesculap Implant Systems, LLC provides solutions for the changing healthcare environment.

Aesculap Implant Systems, LLC

Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Metric
Company Name	Aesculap Implant Systems, LLC	Henry Schein, Inc.
Symbol		HSIC
MSH ID	COM:AESCULAPIMPLANTSYSTEMS	COM:HENRYSCHEIN
Market	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare
Industry	Medical Devices	Medical - Distribution
Country	US	US
Stage
Employee Count		25K
Website	aesculapimplantsystems.com	henryschein.com
LinkedIn
Founders

Metric
Market Cap		8.22B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue		12.34B
Revenue (LTM)
Revenue (NTM)
Gross Profit		3.65B
EBITDA		962M
Operating Income		714M
Net Income		416M
EPS		3.18
Diluted EPS		3.16
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.31
Operating Profit Margin		0.05
EBITDA Margin		0.08
Net Profit Margin		0.03
Return on Equity		0.12
Return on Assets		0.04
Return on Capital Employed		0.08

COM:AESCULAPIMPLANTSYSTEMS

Aesculap Implant Systems, LLC

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		21.96
P/B Ratio		2.68
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		0.77
EV Multiple		7.65

Metric
Days Sales Outstanding		45.23
Days Payables Outstanding		39.72
Days Inventory Outstanding		77.61
Operating Cycle		132.72
Cash Conversion Cycle		89.10
Asset Turnover		1.23

Metric
Operating Cash Flow		500M
Free Cash Flow		313M
Cash Flow to Debt		0.27
Operating Cash Flow/Sales		0.06
Free Cash Flow Yield		0.07

Metric
Cash & Equivalents		171M
Accounts Receivable		-327M
Inventory		1.81B
Goodwill		3.88B
Debt to Capitalization		0.42
Debt to Assets		0.18
Current Ratio		1.97
Quick Ratio		1.02

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.00
R&D to Revenue
SG&A to Revenue